
Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages

Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study

Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States

The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia

The biomarkers are especially crucial for patients with lupus nephritis

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.

The LuxLife full range of vision intraocular lens is available in a range of cylinders spanning from +0.75D to +6.00D.

Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK

Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.


Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.

Research findings compare the rotational stability of a monofocal plus toric IOL with traditional toric lenses

Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting

Carl Zeiss Meditec plans to launch the ZEISS RDP in select countries throughout 2025

LuxIA is designed to screen adult diabetic patients for more-than-mild diabetic retinopathy.

In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment

Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis

Topcon Healthcare has appointed Daniela Ferrara, MD, PhD, as chief medical officer to lead the company’s clinical and medical strategy

Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome


According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.

Canadian investigators urged quick neuro-ophthalmologic referrals to limit the progress of life- and vision-threatening conditions

The US FDA recently approved revakinagene taroretcel-lwey (ENCELTO) for the treatment of idiopathic macular telangiectasia type 2 (MacTel)

A five-step approach to personalise and simplify treatment, leading to higher efficacy